Get started
Author

Cécile Déjou

Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies
2019 · Ivan Perrot, Henri-Alexandre Michaud, et al. · Cell Reports · 427
PDF
Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive Activity
2014 · Jeremy Bastid, Anne Regairaz, et al. · Cancer Immunology Research · 241
The Emerging Role of the IL-17B/IL-17RB Pathway in Cancer
2020 · Jérémy Bastid, Cécile Dejou, et al. · Frontiers in Immunology · 86
PDF
CCL20 and β-Defensin-2 Induce Arrest of Human Th17 Cells on Inflamed Endothelium In Vitro under Flow Conditions
2010 · Soufiane Ghannam, Cécile Dejou, et al. · The Journal of Immunology · 72
PDF
The IL-17B-IL-17 receptor B pathway promotes resistance to paclitaxel in breast tumors through activation of the ERK1/2 pathway
2017 · Emilie Laprevotte, Stéphanie Cochaud, et al. · Oncotarget · 51
PDF
Identification of a regulatory Vδ1 gamma delta T cell subpopulation expressing CD73 in human breast cancer
2020 · Ghita Chabab, Clément Barjon, et al. · Journal of Leukocyte Biology · 50
IL-21 promotes the development of a CD73-positive Vγ9Vδ2 T cell regulatory population
2017 · Clément Barjon, Henri-Alexandre Michaud, et al. · OncoImmunology · 37
PDF
Increased degradation of ATP is driven by memory regulatory T cells in kidney transplantation tolerance
2018 · Maxim Durand, Florian Dubois, et al. · Kidney International · 17
Identification of the Single Immunodominant Region of the Native Human CC Chemokine Receptor 6 Recognized by Mouse Monoclonal Antibodies
2016 · Karim Dorgham, Cécile Dejou, et al. · PLoS ONE · 3
PDF
Abstract 1602: Generation of anti-IL-17B antibodies neutralizing IL-17B-mediated alterations of the immune microenvironment, promotion of tumor cell initiating capacity and chemoresistance
2017 · Emilie Laprevotte, Aurélie Docquier, et al. · Cancer Research · 1
Furan fatty acid supplementation protects against muscle atrophy during cancer cachexia
2026 · Anaïs Deglos, Jennifer Falconi, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
A Novel miR-4745 -KLC2 Axis Regulates Cancer Stem Cell Traits in Colorectal Cancer
2026 · Kuldeep Lahry, Pauline Barraja, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Author Reply to Peer Reviews of Deciphering the tumor-infiltrating CD73+ regulatory γδ T cell ecosystem associated with poor survival of patients with ovarian cancer
2025 · Ghita Chabab, Henri-Alexandre Michaud, et al.
Deciphering the CD73⁺ Regulatory γδ T Cell ecosystem associated with poor survival in Ovarian cancer
2024 · Ghita Chabab, Henri-Alexandre Michaud, et al. · bioRxiv (Cold Spring Harbor Laboratory)
Supplementary Figure 2 from Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive Activity
2023 · Jeremy Bastid, Anne Regairaz, et al.
Supplementary Material and Methods; Figure Legends from Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive Activity
2023 · Jeremy Bastid, Anne Regairaz, et al.
Supplementary Figure 4 from Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive Activity
2023 · Jeremy Bastid, Anne Regairaz, et al.
Supplementary Figure 1 from Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive Activity
2023 · Jeremy Bastid, Anne Regairaz, et al.
Supplementary Figure 3 from Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive Activity
2023 · Jeremy Bastid, Anne Regairaz, et al.
Supplementary Figure 5 from Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive Activity
2023 · Jeremy Bastid, Anne Regairaz, et al.
Data from Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive Activity
2023 · Jeremy Bastid, Anne Regairaz, et al.
Supplementary Material and Methods; Figure Legends from Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive Activity
2023 · Jeremy Bastid, Anne Regairaz, et al.
Supplementary Figure 3 from Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive Activity
2023 · Jeremy Bastid, Anne Regairaz, et al.
Supplementary Figure 1 from Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive Activity
2023 · Jeremy Bastid, Anne Regairaz, et al.
Supplementary Figure 2 from Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive Activity
2023 · Jeremy Bastid, Anne Regairaz, et al.
Works count: 32
Citation count: 985
H-index: 8
I10-index: 8
Year
Topic
Type